INCYTE CORPORATION Payments for (Proceeds from) Investments
INCYTE CORPORATION (INCY) reported Payments for (Proceeds from) Investments of $8.94 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromInvestments · last filed 2019-02-14
- INCYTE CORPORATION payments for (proceeds from) investments for the quarter ending 2018-12-31 was $0.00.
- INCYTE CORPORATION payments for (proceeds from) investments for the quarter ending 2018-09-30 was $0.00.
- INCYTE CORPORATION payments for (proceeds from) investments for the quarter ending 2018-06-30 was -$1.00K.
- INCYTE CORPORATION payments for (proceeds from) investments for the quarter ending 2018-03-31 was $8.94M, a 92.79% decline year-over-year.
- INCYTE CORPORATION payments for (proceeds from) investments for fiscal 2018 was $8.94M, a 92.79% decline from fiscal 2017.
- INCYTE CORPORATION payments for (proceeds from) investments for fiscal 2017 was $123.89M.
- INCYTE CORPORATION payments for (proceeds from) investments for fiscal 2015 was $39.83M.
| Period end | Payments for (Proceeds from) Investments 3 month | Payments for (Proceeds from) Investments 6 month | Payments for (Proceeds from) Investments 9 month | Payments for (Proceeds from) Investments 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $0.00 derived: sum of 2 quarters · filed 2019-02-14 | -$1.00K derived: sum of 3 quarters · filed 2019-02-14 | $8.94M 10-K · filed 2019-02-14 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | -$1.00K derived: sum of 2 quarters · filed 2018-10-30 | $8.94M 10-Q · filed 2018-10-30 | $8.94M derived: sum of 4 quarters · filed 2019-02-14 |
| 2018-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $8.94M 10-Q · filed 2018-07-31 | $8.94M derived: sum of 3 quarters · filed 2019-02-14 | $8.94M derived: sum of 4 quarters · filed 2019-02-14 |
| 2018-03-31 | $8.94M 10-Q · filed 2018-05-01 | $8.94M derived: sum of 2 quarters · filed 2019-02-14 | $8.94M derived: sum of 3 quarters · filed 2019-02-14 | $8.94M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $0.00 derived: sum of 2 quarters · filed 2019-02-14 | $0.00 derived: sum of 3 quarters · filed 2019-02-14 | $123.89M 10-K · filed 2019-02-14 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $0.00 derived: sum of 2 quarters · filed 2018-10-30 | $123.89M 10-Q · filed 2018-10-30 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $123.89M 10-Q · filed 2018-07-31 | ||
| 2017-03-31 | $123.89M 10-Q · filed 2018-05-01 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $0.00 derived: sum of 2 quarters · filed 2018-02-15 | $0.00 derived: sum of 3 quarters · filed 2018-02-15 | $39.83M 10-K · filed 2018-02-15 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $0.00 derived: sum of 2 quarters · filed 2016-11-01 | $39.83M 10-Q · filed 2016-11-01 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $39.83M 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $39.83M 10-Q · filed 2016-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |